PGR

Key Insights for Investors on PGR Stock

It hasn't been a great afternoon session for The Progressive investors, who have watched their shares sink by -1.4% to a price of $190.78. Some of you might be wondering if it's time to buy the dip. If you are considering this, make sure to check the company's fundamentals first to determine if the shares are fairly valued at today's prices.

Trades Below Its Graham Number but Has an Elevated P/B Ratio:

The Progressive Corporation, an insurance holding company, provides personal and commercial auto, personal residential and commercial property, business related general liability, and other specialty property-casualty insurance products and related services in the United States. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 12.38 and an average price to book (P/B) ratio of 1.58. In contrast, The Progressive has a trailing 12 month P/E ratio of 29.0 and a P/B ratio of 5.64.

When we divideThe Progressive's P/E ratio by its expected five-year EPS growth rate, we obtain a PEG ratio of 0.82, which indicates that the market is undervaluing the company's projected growth (a PEG ratio of 1 indicates a fairly valued company). Your analysis of the stock shouldn't end here. Rather, a good PEG ratio should alert you that it may be worthwhile to take a closer look at the stock.

Increasing Revenues but Narrowing Margins:

2018 2019 2020 2021 2022 2023
Revenue (M) $31,979 $39,022 $42,658 $47,702 $49,611 $58,687
Interest Income (M) $166 $190 $217 $219 $244 $262
Operating Margins 10% 13% 17% 9% 2% 6%
Net Margins 8% 10% 13% 7% 1% 5%
Net Income (M) $2,615 $3,970 $5,705 $3,351 $722 $2,741
Depreciation & Amort. (M) $190 $240 $275 $280 $306 $290
Diluted Shares (M) 587 587 588 587 587 588
Earnings Per Share $4.42 $6.72 $9.66 $5.66 $1.18 $4.61
EPS Growth n/a 52.04% 43.75% -41.41% -79.15% 290.68%
Avg. Price $53.69 $66.42 $79.01 $93.11 $110.63 $190.51
P/E Ratio 12.07 9.84 8.14 16.36 92.97 41.24
CAPEX (M) $266 $364 $224 $244 $292 $217
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS